These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 26773960)

  • 1. β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses.
    Ning Y; Xu D; Zhang X; Bai Y; Ding J; Feng T; Wang S; Xu N; Qian K; Wang Y; Qi C
    Int J Cancer; 2016 Jun; 138(11):2713-23. PubMed ID: 26773960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells.
    Tian J; Ma J; Ma K; Guo H; Baidoo SE; Zhang Y; Yan J; Lu L; Xu H; Wang S
    Eur J Immunol; 2013 May; 43(5):1220-30. PubMed ID: 23424024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Glucan enhances cytotoxic T lymphocyte responses by activation of human monocyte-derived dendritic cells via the PI3K/AKT pathway.
    Ding J; Feng T; Ning Y; Li W; Wu Q; Qian K; Wang Y; Qi C
    Hum Immunol; 2015 Mar; 76(2-3):146-54. PubMed ID: 25636576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans.
    Qi C; Cai Y; Gunn L; Ding C; Li B; Kloecker G; Qian K; Vasilakos J; Saijo S; Iwakura Y; Yannelli JR; Yan J
    Blood; 2011 Jun; 117(25):6825-36. PubMed ID: 21531981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.
    Rolinski J; Hus I
    J Immunotoxicol; 2014 Oct; 11(4):311-8. PubMed ID: 24495309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of mGITRL on D2SC/1 cells by particulate β-glucan impairs the suppressive effect of CD4+CD25+ regulatory T cells and enhances the effector T cell proliferation.
    Tian J; Ma J; Wang S; Yan J; Chen J; Tong J; Wu C; Liu Y; Ma B; Mao C; Jiao Z; Shao Q; Lu L; Xu H
    Cell Immunol; 2011; 270(2):183-7. PubMed ID: 21636079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.
    Liu Q; Zhang C; Sun A; Zheng Y; Wang L; Cao X
    J Immunol; 2009 May; 182(10):6207-16. PubMed ID: 19414774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor exosomes block dendritic cells maturation to decrease the T cell immune response.
    Ning Y; Shen K; Wu Q; Sun X; Bai Y; Xie Y; Pan J; Qi C
    Immunol Lett; 2018 Jul; 199():36-43. PubMed ID: 29800589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic Cells and Cancer Immunity.
    Gardner A; Ruffell B
    Trends Immunol; 2016 Dec; 37(12):855-865. PubMed ID: 27793569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Whole glucan particle promotes the maturation of tumor-educated mouse dendritic cells to suppress regulatory T cell differentiation].
    Bai Y; Ning Y; Zhou H; Qi C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Sep; 33(9):1171-1176. PubMed ID: 29089071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble β-glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity.
    Masuda Y; Nawa D; Nakayama Y; Konishi M; Nanba H
    J Leukoc Biol; 2015 Dec; 98(6):1015-25. PubMed ID: 26297795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.
    Fernández A; Oliver L; Alvarez R; Fernández LE; Lee KP; Mesa C
    Hum Vaccin Immunother; 2014; 10(11):3251-60. PubMed ID: 25483674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of TFEB promotes tumor-educated dendritic cells activation to enhance antitumor immune responses.
    Ding J; Xie Y; Sun X; Shao F; Pan J; Chen J; Zhu Z; Qi C
    Mol Immunol; 2022 Jul; 147():30-39. PubMed ID: 35504056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide and IL-12-transduced DCs enhance the antitumor activity of tumor antigen-stimulated DCs and reduce Tregs and MDSCs number.
    Rossowska J; Pajtasz-Piasecka E; Anger N; Wojas-Turek J; Kicielińska J; Piasecki E; Duś D
    J Immunother; 2014; 37(9):427-39. PubMed ID: 25304726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines.
    López M; Aguilera R; Pérez C; Mendoza-Naranjo A; Pereda C; Ramirez M; Ferrada C; Aguillón JC; Salazar-Onfray F
    Immunobiology; 2006; 211(1-2):127-36. PubMed ID: 16446177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-glucan from Aureobasidium pullulans augments the anti-tumor immune responses through activated tumor-associated dendritic cells.
    Shui Y; Hu X; Hirano H; Kusano K; Tsukamoto H; Li M; Hasumi K; Guo WZ; Li XK
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108265. PubMed ID: 34715491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of regulatory T cells in cancer immunity.
    Takeuchi Y; Nishikawa H
    Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting myeloid cells using nanoparticles to improve cancer immunotherapy.
    Amoozgar Z; Goldberg MS
    Adv Drug Deliv Rev; 2015 Aug; 91():38-51. PubMed ID: 25280471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine.
    Ko HJ; Lee JM; Kim YJ; Kim YS; Lee KA; Kang CY
    J Immunol; 2009 Feb; 182(4):1818-28. PubMed ID: 19201833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.